|Bid||9.80 x N/A|
|Ask||10.00 x N/A|
|Day's Range||10.10 - 10.10|
|52 Week Range||7.40 - 23.00|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Here is how Akero Therapeutics, Inc. (AKRO) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
The mean of analysts' price targets for Akero Therapeutics, Inc. (AKRO) points to a 91.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.